Literature DB >> 17988995

Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System.

Yoshiko Atsuta1, Ritsuro Suzuki, Ayami Yoshimi, Hisashi Gondo, Junji Tanaka, Akira Hiraoka, Koji Kato, Ken Tabuchi, Masahiro Tsuchida, Yasuo Morishima, Makoto Mitamura, Keisei Kawa, Shunichi Kato, Tokiko Nagamura, Minoko Takanashi, Yoshihisa Kodera.   

Abstract

There are 4 registries of hematopoietic cell transplantation in Japan; the Japan Society for Hematopoietic Cell Transplantation (JSHCT), Japanese Society of Pediatric Hematology, Japan Marrow Donor Program, and Japan Cord Blood Bank Network; each play an important role in society by reporting the number and outcomes of transplantations and contributing new findings obtained from studies on individual topics. However, there have been a number of issues with the difficulty of analyzing data in overlapping registries and multiple databases at centers affiliated with each of the 4 registry organizations. JSHCT was pivotal in orchestrating the computerization and unification of hematopoietic stem cell transplantation registries for the purpose of resolving these issues and providing a more accurate awareness of hematopoietic stem cell transplantations being performed in Japan. JSHCT played a central role in developing the "Transplant Registry Unified Management Program (TRUMP)" to enable transplantation institutes to manage patient information with emphases on convenience to institutes, safety of patient information, and quality of data management. While enhancing domestic registries, the program seeks to coordinate with other hematopoietic cell transplantation registries around the world to contribute to the development of registries throughout Asia.

Entities:  

Mesh:

Year:  2007        PMID: 17988995     DOI: 10.1532/IJH97.06239

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  30 in total

1.  Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey.

Authors:  Vanderson Rocha; Myriam Labopin; Eliane Gluckman; Ray Powles; William Arcese; Andrea Bacigalupo; Josy Reiffers; Arturo Iriondo; Olle Ringdén; Tapani Ruutu; Francesco Frassoni
Journal:  J Clin Oncol       Date:  2002-11-01       Impact factor: 44.544

2.  Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia.

Authors:  Y Kodera; Y Morishima; S Kato; Y Akiyama; H Sao; T Matsuyama; K Kawa; H Sakamaki; S Nakagawa; N Hirabayashi; H Dohi; S Okamoto; A Hiraoka; H Gondo; M Tsuchida; H O; M Harada; S Asano; T Juji; T Sasazuki; F Takaku
Journal:  Bone Marrow Transplant       Date:  1999-11       Impact factor: 5.483

3.  Superior survival of blood and marrow stem cell recipients given maternal grafts over recipients given paternal grafts.

Authors:  S Tamaki; T Ichinohe; K Matsuo; N Hamajima; N Hirabayashi; H Dohy
Journal:  Bone Marrow Transplant       Date:  2001-08       Impact factor: 5.483

4.  The Japanese cord blood bank network experience with cord blood transplantation from unrelated donors for haematological malignancies: an evaluation of graft-versus-host disease prophylaxis.

Authors:  Hirokazu Nishihira; Koji Kato; Keiichi Isoyama; Tsuneo A Takahashi; Shunro Kai; Shunichi Kato; Minoko Takanashi; Norihiro Sato; Hiroyuki Sato; Kohichi Kitajima; Tomoki Naoe; Hidehiko Saito
Journal:  Br J Haematol       Date:  2003-02       Impact factor: 6.998

5.  Health-related quality of life of unrelated bone marrow donors in Japan.

Authors:  Mina Nishimori; Yoshitsugu Yamada; Keiko Hoshi; Yuichi Akiyama; Yasutaka Hoshi; Yasuo Morishima; Masahiro Tsuchida; Shunichi Fukuhara; Yoshihisa Kodera
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

6.  Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program.

Authors:  Seiji Kojima; Takaharu Matsuyama; Shunichi Kato; Hisato Kigasawa; Ryoji Kobayashi; Atsushi Kikuta; Hisashi Sakamaki; Koichiro Ikuta; Masahiro Tsuchida; Yasutaka Hoshi; Yasuo Morishima; Yoshihisa Kodera
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

7.  Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

Authors:  Stephanie J Lee; John P Klein; A John Barrett; Olle Ringden; Joseph H Antin; Jean-Yves Cahn; Matthew H Carabasi; Robert Peter Gale; Sergio Giralt; Gregory A Hale; Osman Ilhan; Philip L McCarthy; Gerard Socie; Leo F Verdonck; Daniel J Weisdorf; Mary M Horowitz
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

8.  Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.

Authors:  T Sasazuki; T Juji; Y Morishima; N Kinukawa; H Kashiwabara; H Inoko; T Yoshida; A Kimura; T Akaza; N Kamikawaji; Y Kodera; F Takaku
Journal:  N Engl J Med       Date:  1998-10-22       Impact factor: 91.245

9.  Allogeneic myeloablative transplantation for patients aged 50 years and over.

Authors:  M Yanada; N Emi; T Naoe; H Sakamaki; T Iseki; N Hirabayashi; T Karasuno; S Chiba; Y Atsuta; N Hamajima; S Takahashi; S Kato
Journal:  Bone Marrow Transplant       Date:  2004-07       Impact factor: 5.483

10.  Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party.

Authors:  I Kataoka; M Kami; S Takahashi; Y Kodera; S Miyawaki; N Hirabayashi; S Okamoto; N Matsumoto; Y Miyazaki; Y Morishita; O Asai; A Maruta; T Yoshida; M Imamura; N Hamajima; K Matsuo; M Harada; S Mineishi
Journal:  Bone Marrow Transplant       Date:  2004-10       Impact factor: 5.483

View more
  80 in total

1.  Influence of melphalan plus fludarabine-conditioning regimen in elderly patients aged ⩾55 years with hematological malignancies.

Authors:  K Miyao; M Sawa; Y Kuwatsuka; Y Ozawa; T Kato; A Kohno; H Sao; T Nishida; H Iida; K Naito; H Tsurumi; H Taji; S Mizuta; S Kusumoto; K Nakase; Y Morishita; N Kawashima; K Miyamura; M Murata
Journal:  Bone Marrow Transplant       Date:  2015-10-05       Impact factor: 5.483

2.  Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data).

Authors:  Yoshiko Atsuta
Journal:  Int J Hematol       Date:  2015-11-07       Impact factor: 2.490

3.  Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation.

Authors:  M Kato; T Yamashita; R Suzuki; K Matsumoto; H Nishimori; S Takahashi; K Iwato; C Nakaseko; T Kondo; K Imada; F Kimura; T Ichinohe; Y Hashii; K Kato; Y Atsuta; S Taniguchi; T Fukuda
Journal:  Leukemia       Date:  2016-02-12       Impact factor: 11.528

4.  Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation.

Authors:  K Kawamura; J Kanda; S Fuji; M Murata; K Ikegame; K Yoshioka; T Fukuda; Y Ozawa; N Uchida; K Iwato; T Sakura; M Hidaka; H Hashimoto; T Ichinohe; Y Atsuta; Y Kanda
Journal:  Bone Marrow Transplant       Date:  2017-07-17       Impact factor: 5.483

5.  Enactment of a law for governmental support of the use of cord blood, and ethical issues.

Authors:  Young-Ho Lee; Yeundek Chung
Journal:  Int J Stem Cells       Date:  2012-05       Impact factor: 2.500

6.  Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan.

Authors:  Masamitsu Yanada; Akiyoshi Takami; Shohei Mizuno; Jinichi Mori; Takaaki Chou; Kensuke Usuki; Hitoji Uchiyama; Itsuto Amano; Shiro Fujii; Toshihiro Miyamoto; Takeshi Saito; Tomohiko Kamimura; Tatsuo Ichinohe; Takahiro Fukuda; Shinichiro Okamoto; Yoshiko Atsuta; Shingo Yano
Journal:  Int J Hematol       Date:  2019-10-14       Impact factor: 2.490

7.  Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populations.

Authors:  Yachiyo Kuwatsuka; Yoshiko Atsuta; Mary M Horowitz; Jiro Inagaki; Junya Kanda; Koji Kato; Katsuyoshi Koh; Mei-Jie Zhang; Mary Eapen
Journal:  Biol Blood Marrow Transplant       Date:  2014-02-10       Impact factor: 5.742

8.  Single cord blood transplantation for acute myeloid leukemia patients aged 60 years or older: a retrospective study in Japan.

Authors:  Masamichi Isobe; Takaaki Konuma; Masayoshi Masuko; Naoyuki Uchida; Shigesaburo Miyakoshi; Yasuhiro Sugio; Shuro Yoshida; Masatsugu Tanaka; Yoshiko Matsuhashi; Norimichi Hattori; Makoto Onizuka; Nobuyuki Aotsuka; Yasushi Kouzai; Atsushi Wake; Takafumi Kimura; Tatsuo Ichinohe; Yoshiko Atsuta; Masamitsu Yanada
Journal:  Ann Hematol       Date:  2021-02-23       Impact factor: 3.673

9.  Effect of methotrexate dose in graft-versus-host disease prophylaxis after single-unit cord blood transplantation in adult acute myeloid leukemia.

Authors:  Seitaro Terakura; Yachiyo Kuwatsuka; Junichi Sugita; Satoshi Takahashi; Yukiyasu Ozawa; Kazutaka Ozeki; Satoshi Yoshioka; Hirohisa Nakamae; Toshiro Kawakita; Masashi Sawa; Satoshi Morishige; Yuho Najima; Yuna Katsuoka; Emiko Sakaida; Yasuji Kouzai; Takafumi Kimura; Tatsuo Ichinohe; Takahiro Fukuda; Yoshiko Atsuta; Makoto Murata; Takanori Teshima
Journal:  Int J Hematol       Date:  2021-02-21       Impact factor: 2.490

10.  Hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma.

Authors:  Naoto Fujita; Ryoji Kobayashi; Yoshiko Atsuta; Fuminori Iwasaki; Junji Suzumiya; Yoji Sasahara; Masami Inoue; Katsuyoshi Koh; Tsukasa Hori; Hiroaki Goto; Tatsuo Ichinohe; Yoshiko Hashii; Koji Kato; Ritsuro Suzuki; Tetsuo Mitsui
Journal:  Int J Hematol       Date:  2019-01-30       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.